DE69720057D1 - Vorrichtung und verfahren zur erhöhung des transdermalen wirkstoffeflusses - Google Patents

Vorrichtung und verfahren zur erhöhung des transdermalen wirkstoffeflusses

Info

Publication number
DE69720057D1
DE69720057D1 DE69720057T DE69720057T DE69720057D1 DE 69720057 D1 DE69720057 D1 DE 69720057D1 DE 69720057 T DE69720057 T DE 69720057T DE 69720057 T DE69720057 T DE 69720057T DE 69720057 D1 DE69720057 D1 DE 69720057D1
Authority
DE
Germany
Prior art keywords
increasing
active substance
substance flow
transdermal active
transdermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69720057T
Other languages
English (en)
Other versions
DE69720057T2 (de
Inventor
Felix Theeuwes
P Neukermans
J Cormier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of DE69720057D1 publication Critical patent/DE69720057D1/de
Publication of DE69720057T2 publication Critical patent/DE69720057T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/20—Surgical instruments, devices or methods for vaccinating or cleaning the skin previous to the vaccination
    • A61B17/205—Vaccinating by means of needles or other puncturing devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A61B2010/008—Interstitial fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A61N1/303—Constructional details
    • A61N1/306—Arrangements where at least part of the apparatus is introduced into the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Electrotherapy Devices (AREA)
  • Nonmetallic Welding Materials (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Surgical Instruments (AREA)
DE69720057T 1996-12-20 1997-12-16 Vorrichtung und verfahren zur erhöhung des transdermalen wirkstoffeflusses Expired - Lifetime DE69720057T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3344096P 1996-12-20 1996-12-20
PCT/US1997/023274 WO1998028037A1 (en) 1996-12-20 1997-12-16 Device and method for enhancing transdermal agent flux

Publications (2)

Publication Number Publication Date
DE69720057D1 true DE69720057D1 (de) 2003-04-24
DE69720057T2 DE69720057T2 (de) 2003-09-25

Family

ID=21870407

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69720057T Expired - Lifetime DE69720057T2 (de) 1996-12-20 1997-12-16 Vorrichtung und verfahren zur erhöhung des transdermalen wirkstoffeflusses

Country Status (11)

Country Link
EP (1) EP0957972B1 (de)
JP (1) JP4153999B2 (de)
KR (1) KR100453132B1 (de)
CN (1) CN1133472C (de)
AT (1) ATE234649T1 (de)
AU (1) AU722574B2 (de)
CA (1) CA2271167C (de)
DE (1) DE69720057T2 (de)
DK (1) DK0957972T3 (de)
ES (1) ES2195190T3 (de)
WO (1) WO1998028037A1 (de)

Families Citing this family (126)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3316820B2 (ja) 1995-12-28 2002-08-19 シィグナス インコーポレィティド 被験者の生理的分析物の継続モニタリング装置及び方法
AU757230B2 (en) * 1997-12-11 2003-02-06 Alza Corporation Device for enhancing transdermal agent flux
WO1999029365A1 (en) 1997-12-11 1999-06-17 Alza Corporation Device for enhancing transdermal agent flux
EP1911488A3 (de) 1997-12-11 2008-12-03 Alza Corporation Vorrichtung zur Verstärkung des Flusses transdermaler Mittel
US7344499B1 (en) 1998-06-10 2008-03-18 Georgia Tech Research Corporation Microneedle device for extraction and sensing of bodily fluids
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
DE69921489T2 (de) * 1998-08-31 2005-10-27 Johnson & Johnson Consumer Companies, Inc. Elektrotransportvorrichtung mit klingen
US20040171980A1 (en) 1998-12-18 2004-09-02 Sontra Medical, Inc. Method and apparatus for enhancement of transdermal transport
TR200103018T2 (tr) 1999-04-19 2002-02-21 Beecham Biologicals S.A. Smithkline İmmünostimülatör oligonükleotid ve saponin içeren katkı bileşikleri.
US6558670B1 (en) 1999-04-19 2003-05-06 Smithkline Beechman Biologicals S.A. Vaccine adjuvants
ATE462468T1 (de) * 1999-06-04 2010-04-15 Georgia Tech Res Inst Vorrichtungen zur vergrösserten penetration von mikronadeln in biologischen hautschichten
US6611707B1 (en) 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
US6743211B1 (en) 1999-11-23 2004-06-01 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
EP1189660B1 (de) * 1999-06-08 2006-05-03 Altea Therapeutics Corporation Vorrichtung zur mikroporation eines biologischen gewebes mittels einer filmgewebe schnittstellenvorrichtung und verfahren
US6890553B1 (en) 1999-07-08 2005-05-10 Johnson & Johnson Consumer Companies, Inc. Exothermic topical delivery device
AU6076200A (en) 1999-07-08 2001-01-30 Johnson & Johnson Consumer Companies, Inc. Exothermic bandage
US7113821B1 (en) 1999-08-25 2006-09-26 Johnson & Johnson Consumer Companies, Inc. Tissue electroperforation for enhanced drug delivery
US7133717B2 (en) 1999-08-25 2006-11-07 Johnson & Johnson Consumer Companies, Inc. Tissue electroperforation for enhanced drug delivery and diagnostic sampling
DE60024312T2 (de) 1999-12-10 2006-08-17 Alza Corp., Mountain View Transdermale Wirkstoffabgabe von makromolekularen Wirkstoffen und Vorrichtung hierfür
CN100402106C (zh) * 1999-12-10 2008-07-16 阿尔萨公司 用于持续经过皮肤进行药物输送的皮肤处理装置
US6622035B1 (en) * 2000-01-21 2003-09-16 Instrumentarium Corp. Electrode for measurement of weak bioelectrical signals
US7404815B2 (en) 2000-05-01 2008-07-29 Lifescan, Inc. Tissue ablation by shear force for sampling biological fluids and delivering active agents
EP1315459A1 (de) * 2000-08-24 2003-06-04 Alza Corporation Verfahren zur transdermalen nukleinsäureentnahme
US6749575B2 (en) 2001-08-20 2004-06-15 Alza Corporation Method for transdermal nucleic acid sampling
WO2002019985A2 (en) 2000-09-08 2002-03-14 Alza Corporation Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
CA2425537C (en) 2000-10-13 2009-09-08 Alza Corporation Microblade array impact applicator
KR20030068136A (ko) * 2000-10-13 2003-08-19 알자 코포레이션 미세 돌기부로 피부를 천공하기 위한 장치 및 방법
US7419481B2 (en) 2000-10-13 2008-09-02 Alza Corporation Apparatus and method for piercing skin with microprotrusions
PL360977A1 (en) 2000-10-13 2004-09-20 Alza Corporation Microprotrusion member retainer for impact applicator
US6821281B2 (en) * 2000-10-16 2004-11-23 The Procter & Gamble Company Microstructures for treating and conditioning skin
EP2266603B1 (de) 2000-10-18 2012-09-12 GlaxoSmithKline Biologicals S.A. Impfstoffe gegen Krebs
CN1239212C (zh) 2000-10-26 2006-02-01 阿尔扎公司 具有涂敷的微突出物的经皮肤的给药装置
WO2002064193A2 (en) 2000-12-14 2002-08-22 Georgia Tech Research Corporation Microneedle devices and production thereof
US7027478B2 (en) 2000-12-21 2006-04-11 Biovalve Technologies, Inc. Microneedle array systems
US6855372B2 (en) 2001-03-16 2005-02-15 Alza Corporation Method and apparatus for coating skin piercing microprojections
MXPA03009603A (es) * 2001-04-20 2004-12-06 Johnson & Johnson Arreglo de microproyeccion que tiene un agente benefico que contiene un recubrimiento.
EP1752189A3 (de) 2001-04-20 2007-02-21 Alza Corporation Mikroprojektionsanordnung mit einem Überzug, der ein vorteilhaftes Mittel enthält
AU2002327675A1 (en) 2001-09-19 2003-04-01 Biovalve Technologies, Inc. Microneedles, microneedle arrays, and systems and methods relating to same
US8920375B2 (en) 2001-09-21 2014-12-30 Valeritas, Inc. Gas pressure actuated microneedle arrays, and systems and methods relating to same
US6908453B2 (en) * 2002-01-15 2005-06-21 3M Innovative Properties Company Microneedle devices and methods of manufacture
EP2319578B1 (de) * 2002-03-11 2016-11-02 Nitto Denko Corporation Patch-System zur transdermalen Arzneimittelverabreichung, Herstellungsverfahren und Verwendungsverfahren
AR042815A1 (es) * 2002-12-26 2005-07-06 Alza Corp Dispositivo de suministro de agente activo que tiene miembros compuestos
JP5456234B2 (ja) 2003-06-30 2014-03-26 アルザ・コーポレーシヨン 非揮発性の対イオンを含有する被覆された微小突起のための製剤
US8353861B2 (en) 2003-09-18 2013-01-15 Texmac, Inc. Applicator for applying functional substances into human skin
CN1897898A (zh) 2003-10-24 2007-01-17 阿尔扎公司 用于增强透皮药物传递的预处理方法和系统
BRPI0415986A (pt) 2003-10-28 2007-01-23 Alza Corp método e aparelho para reduzir a incidência do uso de tabaco
BRPI0415629A (pt) 2003-10-31 2006-12-12 Alza Corp aplicador auto-atuador para conjunto de microprojeções
WO2005051476A1 (en) * 2003-11-28 2005-06-09 Acrux Dds Pty Ltd Method and system for rapid transdermal administration
GB0402131D0 (en) 2004-01-30 2004-03-03 Isis Innovation Delivery method
AU2005272700A1 (en) * 2004-08-11 2006-02-23 Alza Corporation Apparatus and method for transdermal delivery of natriuretic peptides
CA2584290A1 (en) 2004-09-22 2006-03-30 Glaxosmithkline Biologicals S.A. Staphylococcal immunogenic compositions
WO2006089056A2 (en) * 2005-02-16 2006-08-24 Alza Corporation Apparatus and method for transdermal delivery of erythropoetin-based agents
WO2006105233A1 (en) * 2005-03-28 2006-10-05 Alza Corporation Microprojections with capillary control features and method
CA2613114C (en) * 2005-06-27 2015-02-24 3M Innovative Properties Company Microneedle cartridge assembly and method of applying
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
SI3017827T1 (sl) 2005-12-22 2019-01-31 Glaxosmithkline Biologicals S.A. Cepivo na osnovi konjugata pnevmokoknega polisaharida
JP2009522288A (ja) 2005-12-28 2009-06-11 アルザ コーポレイション 安定な治療剤形
SG170090A1 (en) 2006-03-30 2011-04-29 Glaxosmithkline Biolog Sa Immunogenic composition
EP2076312A4 (de) * 2006-04-20 2013-09-04 3M Innovative Properties Co Geformte artikel mit mikronadel-anordnungen
DE102006028987A1 (de) * 2006-06-24 2007-12-27 Lts Lohmann Therapie-Systeme Ag Ultraschallverstärktes transdermales therapeutisches System
SI2086582T1 (sl) 2006-10-12 2013-02-28 Glaxosmithkline Biologicals S.A. Cepivo, ki obsega emulzijo olja v vodi kot adjuvans
KR101151202B1 (ko) 2006-10-12 2012-06-11 글락소스미스클라인 바이오로지칼즈 에스.에이. 수중유 에멀젼 애주번트를 포함하는 백신
PL2152358T3 (pl) 2007-04-27 2011-09-30 Echo Therapeutics Inc Urządzenie do realizacji permeacji skórnej dla pomiaru analitów i przezskórnego podawania leku
WO2008137747A1 (en) 2007-05-02 2008-11-13 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
US8771781B2 (en) 2007-05-15 2014-07-08 Hisamitsu Pharmaceutical Co., Inc. Method of coating microneedle
HUE026853T2 (en) 2007-06-26 2016-08-29 Glaxosmithkline Biologicals Sa Vaccine containing Streptococcus pneumoniae capsular polysaccharide conjugates
WO2009079712A1 (en) 2007-12-24 2009-07-02 The University Of Queensland Coating method
CN102007066B (zh) 2008-02-07 2013-06-26 昆士兰大学 贴片制造
GB0802447D0 (en) 2008-02-09 2008-03-19 Univ Manchester Fluid extraction device, associated materials and methods
CN102099052A (zh) 2008-04-16 2011-06-15 葛兰素史密丝克莱恩生物有限公司 疫苗
CA2760680A1 (en) * 2008-05-23 2009-11-26 The University Of Queensland Analyte detection by microneedle patch with analyte selective reagents
EP2349209A2 (de) 2008-09-26 2011-08-03 Nanobio Corporation Therapeutische zusammensetzungen in nanoemulsionsform und anwendungsverfahren dafür
US9974844B2 (en) 2008-11-17 2018-05-22 The Regents Of The University Of Michigan Cancer vaccine compositions and methods of using the same
EP2383013A4 (de) 2008-12-26 2012-11-28 Hisamitsu Pharmaceutical Co Mikronadelvorrichtung
CN102300601A (zh) 2009-01-30 2011-12-28 久光制药株式会社 微针装置
ES2691259T3 (es) 2009-06-10 2018-11-26 Hisamitsu Pharmaceutical Co., Inc. Dispositivo de microagujas
WO2010148111A1 (en) 2009-06-16 2010-12-23 The Regents Of The University Of Michigan Nanoemulsion vaccines
CN102470179A (zh) 2009-07-23 2012-05-23 久光制药株式会社 微针阵列
GB0913681D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
CN102770176B (zh) 2010-02-24 2015-11-25 久光制药株式会社 微针装置及其制造方法
GB201003920D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Method of treatment
GB201003922D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Conjugation process
WO2011148995A1 (ja) 2010-05-28 2011-12-01 久光製薬株式会社 微小突起付きアレイ
JP5597254B2 (ja) 2010-05-28 2014-10-01 久光製薬株式会社 微小突起付きアレイを有するデバイス
US8658603B2 (en) 2010-06-16 2014-02-25 The Regents Of The University Of Michigan Compositions and methods for inducing an immune response
WO2012006677A1 (en) 2010-07-14 2012-01-19 The University Of Queensland Patch applying apparatus
CN103391798A (zh) 2011-02-24 2013-11-13 久光制药株式会社 微针装置用glp-1类似物组合物
US8696637B2 (en) * 2011-02-28 2014-04-15 Kimberly-Clark Worldwide Transdermal patch containing microneedles
GB201103836D0 (en) 2011-03-07 2011-04-20 Glaxosmithkline Biolog Sa Conjugation process
AU2012257771C1 (en) 2011-05-17 2015-12-03 Glaxosmithkline Biologicals S.A. Vaccine against Streptococcus pneumoniae
AU2012323392A1 (en) 2011-10-12 2014-04-24 3M Innovative Properties Company Integrated microneedle array delivery system
EP4233839A3 (de) 2011-10-12 2023-09-27 Vaxxas Pty Limited Abgabegerät
JP2013153959A (ja) * 2012-01-30 2013-08-15 Toppan Printing Co Ltd 針状体の構造
CN103356243A (zh) * 2012-03-27 2013-10-23 马广 新型皮肤采样器
WO2014066663A1 (en) 2012-10-24 2014-05-01 Platelet Targeted Therapeutics, Llc Platelet targeted treatment
EP3027263A1 (de) 2013-07-30 2016-06-08 ZP Opco, Inc. Flacher mikronadelfeldapplikator
KR101977449B1 (ko) 2013-11-01 2019-05-10 유니버시티에트 이 오슬로 알부민 변이체 및 이의 용도
CA2929126C (en) 2013-11-13 2020-01-07 University Of Oslo Outer membrane vesicles and uses thereof
EP3069138B1 (de) 2013-11-15 2019-01-09 Oslo Universitetssykehus HF Ctl-peptid-epitope und antigen-spezifische t-zellen, verfahren zu deren entdeckung und verwendungen davon
EP3204039B1 (de) 2014-10-10 2022-06-08 The Regents Of The University Of Michigan Nanoemulsionszusammensetzungen zur prävention, unterdrückung oder eliminierung von allergischen und entzündlichen erkrankungen
AU2015252119A1 (en) 2014-11-07 2016-05-26 Takeda Vaccines, Inc. Hand, foot, and mouth vaccines and methods of manufacture and use thereof
AR102547A1 (es) 2014-11-07 2017-03-08 Takeda Vaccines Inc Vacunas contra la enfermedad de manos, pies y boca y métodos de fabricación y su uso
EP4218892A1 (de) 2015-02-02 2023-08-02 Vaxxas Pty Limited Mikroprojektionsarrayapplikator
WO2016141320A2 (en) 2015-03-05 2016-09-09 Northwestern University Non-neuroinvasive viruses and uses thereof
US11103259B2 (en) 2015-09-18 2021-08-31 Vaxxas Pty Limited Microprojection arrays with microprojections having large surface area profiles
CA2999538A1 (en) 2015-09-28 2017-04-06 Vaxxas Pty Limited Microprojection arrays with enhanced skin penetrating properties and methods thereof
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
WO2017196979A1 (en) 2016-05-10 2017-11-16 The Regents Of The University Of Michigan Emulsion adjuvant for intramuscular, intradermal and subcutaneous administration
US11173207B2 (en) 2016-05-19 2021-11-16 The Regents Of The University Of Michigan Adjuvant compositions
GB201610599D0 (en) 2016-06-17 2016-08-03 Glaxosmithkline Biologicals Sa Immunogenic Composition
WO2018096396A1 (en) 2016-11-22 2018-05-31 University Of Oslo Albumin variants and uses thereof
CN110114069B (zh) 2016-12-26 2022-03-04 久光制药株式会社 微针装置
WO2018155431A1 (ja) 2017-02-24 2018-08-30 久光製薬株式会社 マイクロニードルデバイス
ES2960937T3 (es) 2017-03-31 2024-03-07 Vaxxas Pty Ltd Dispositivo y método para recubrir superficies
US11175128B2 (en) 2017-06-13 2021-11-16 Vaxxas Pty Limited Quality control of substrate coatings
MX2019015524A (es) 2017-06-23 2020-09-10 Univ Maryland Composiciones inmunogenicas.
WO2019023757A1 (en) 2017-08-04 2019-02-07 Vaxxas Pty Limited COMPACT MECHANICAL HIGH ENERGY STORAGE ACTUATOR WITH LOW TRIGGER STRENGTH FOR ADMINISTRATION OF MICROPROJECTION NETWORK (PRM) PATCHES
EP3678699A1 (de) 2017-09-07 2020-07-15 University Of Oslo Impfstoffmoleküle
EP3678698A1 (de) 2017-09-07 2020-07-15 University Of Oslo Impfstoffmoleküle
SG11202003949TA (en) 2017-11-03 2020-05-28 Takeda Vaccines Inc Method for inactivating zika virus and for determining the completeness of inactivation
GB201721582D0 (en) 2017-12-21 2018-02-07 Glaxosmithkline Biologicals Sa S aureus antigens and immunogenic compositions
GB201721576D0 (en) 2017-12-21 2018-02-07 Glaxosmithkline Biologicals Sa Hla antigens and glycoconjugates thereof
WO2021206294A1 (ko) * 2020-04-06 2021-10-14 (주)일론 화장품 흡수 유도용 미세바늘이 장착된 화장품 주입기 및 이의 제작방법
WO2023039108A1 (en) 2021-09-08 2023-03-16 Affinivax, Inc. Coronavirus vaccine
WO2024229176A1 (en) 2023-05-04 2024-11-07 Affinivax, Inc. Rhizavidin variants

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3964482A (en) 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
EP0429842B1 (de) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Vorrichtung zur transdermalen Applikation von Protein- oder Peptid-Medikamenten
ATE131392T1 (de) 1990-03-30 1995-12-15 Alza Corp Gerät zur iontophoretischen verabreichung von medikamenten
DE69109690T3 (de) 1990-10-29 1999-06-02 Alza Corp., Palo Alto, Calif. Elektrode zur iontophoretischen verabreichung von medikamenten und verfahren zur hydratation derselben.
US5279544A (en) 1990-12-13 1994-01-18 Sil Medics Ltd. Transdermal or interdermal drug delivery devices
CA2205444A1 (en) * 1994-12-09 1996-06-13 Novartis Ag Transdermal system
AU5869796A (en) * 1995-05-22 1996-12-11 Ned A. Godshall Micromechanical patch for enhancing the delivery of compound s through the skin
DE19525607A1 (de) * 1995-07-14 1997-01-16 Boehringer Ingelheim Kg Transcorneales Arzneimittelfreigabesystem

Also Published As

Publication number Publication date
DE69720057T2 (de) 2003-09-25
ATE234649T1 (de) 2003-04-15
CA2271167A1 (en) 1998-07-02
WO1998028037A1 (en) 1998-07-02
KR20000053006A (ko) 2000-08-25
CN1233967A (zh) 1999-11-03
EP0957972A1 (de) 1999-11-24
ES2195190T3 (es) 2003-12-01
AU5529498A (en) 1998-07-17
JP4153999B2 (ja) 2008-09-24
CA2271167C (en) 2007-01-09
DK0957972T3 (da) 2003-07-21
JP2001506904A (ja) 2001-05-29
AU722574B2 (en) 2000-08-10
EP0957972B1 (de) 2003-03-19
KR100453132B1 (ko) 2004-10-15
CN1133472C (zh) 2004-01-07

Similar Documents

Publication Publication Date Title
DE69720057D1 (de) Vorrichtung und verfahren zur erhöhung des transdermalen wirkstoffeflusses
DE69806963D1 (de) Vorrichtung zur erhöhung des transdermalen wirkstoffeflusses
ATE406935T1 (de) Vorrichtung zur verbesserung des transdermalen flusses von medikamenten
DE69017950D1 (de) Verfahren und Vorrichtung zur Sichtbarmachung der Blutströmung.
DE69839641D1 (de) Verfahren und vorrichtung zur blutdruckmessung
DE59810147D1 (de) Vorrichtung und Verfahren zur Bedienung medizintechnischer Geräte
ATE324922T1 (de) Vorrichtung zur mikroporation eines biologischen gewebes mittels einer filmgewebe schnittstellenvorrichtung und verfahren
TW349872B (en) Device and method for enhancing transdermal flux of agents being delivered or sampled
DE69840531D1 (de) Vorrichtung und verfahren zur ermittlung des gesichtsfeldes
DE69507686D1 (de) Vorrichtung zum Einschneiden und Aufdehnen von Blutgefässen
DE68914466D1 (de) Verfahren und vorrichtung zur verwendung von schwingungen am menschlichen körper.
DE68918971D1 (de) Vorrichtung und Verfahren zur persönlichen Identifizierung.
DE69624088D1 (de) System und Verfahren für eine effiziente Schnittstelle zur ATM-Anpassung und Gerätebetrieb
DE69909281D1 (de) Vorrichtung zur präsentation und abgabe von mehreren produkten
DE69633294D1 (de) Gerät zur infusion und aspiration in, bzw. aus knochen
DE69635174D1 (de) Nichtinvasive Vorrichtung zur Blutuntersuchung
DE3587725D1 (de) Zahnpflegemittel, Vorrichtung und Verfahren zur Lagerung und Verabreichung desselben.
ATE302041T1 (de) Vorrichtung zur erhöhung des transdermalen wirkstoffeflusses
DE3683958D1 (de) Verfahren und vorrichtung zur guetepruefung von masken.
DE69840883D1 (de) Komplexes orthogonales Spreizverfahren für Mehrkanäle und zugehörende Vorrichtung
DE69528618D1 (de) Verfahren und Vorrichtung zur Bestimmung des Lagerstättendrucks
DE69015196D1 (de) Verfahren und Vorrichtung zur automatischen Blutdrucküberwachung.
DE69527916D1 (de) Nicht-invasive Vorrichtung zur Blut-Analyse
DE69934777D1 (de) Substanz aktivirendes verfahren-und vorrichtung
DE59709421D1 (de) Vorrichtung zur Ortung und Zertrümmerung von Konkrementen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition